AquaPass Device in Treatment of CHF Patients

NACompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

February 20, 2022

Primary Completion Date

August 14, 2023

Study Completion Date

December 12, 2023

Conditions
Chronic Heart FailureEdemaCHF
Interventions
DEVICE

The AquaPass System

The system is a non-invasive, multiple use device intended for use at the hospital, at the outpatient clinic settings or at home. The system administers warm, dry air around the patients' body in order to create environmental conditions that increase the patients' sweat rate. Throughout the treatment, fluids from the interstitial compartment are removed from the body by the eccrine sweat glands.

Trial Locations (2)

3109601

Rambam Health Care Campus, Haifa

Unknown

Rabin medical center, campus Belinson, Petah Tikva

Sponsors
All Listed Sponsors
lead

AquaPass Medical Ltd.

INDUSTRY

NCT05843201 - AquaPass Device in Treatment of CHF Patients | Biotech Hunter | Biotech Hunter